ADMA Biologics Competitors and Similar CompaniesClear all
Autolus's competitors and similar companies include Array BioPharma.
 Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2014 | Founding Date 1998 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations London, GB HQ London, GB | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 647 | Employees 110 |
Financial | ||
Revenue (est.) | Revenue (est.) $75.4m (FY, 2025) | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $86.6m (FY, 2025) | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit ($10.7m) (FY, 2025) | Gross profit $114.4m (FY, 2018) |
Net income | Net income ($287.5m) (FY, 2025) | Net income ($147.7m) (FY, 2018) |
For sources of this data, please see the company profile
View Company Profiles
Array BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company